메뉴 건너뛰기




Volumn 75, Issue 1, 2014, Pages 6-7

Investing in antimicrobial resistance research

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ECONOMICS; EDITORIAL; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH;

EID: 84897020167     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2014.75.1.6     Document Type: Editorial
Times cited : (1)

References (9)
  • 1
    • 84884597711 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, (accessed 13 November 2013)
    • Centers for Disease Control and Prevention (2013) Antibiotic resistance threats in the United States, 2013. www.cdc.gov/drugresistance/threat-report- 2013/ (accessed 13 November 2013)
    • (2013) Antibiotic Resistance Threats in the United States, 2013
  • 2
    • 84902008936 scopus 로고    scopus 로고
    • Department of Health, (accessed 23 November 2013)
    • Department of Health (2012) ESBLs: A Threat to Human and Animal Health. https://www.gov.uk/government/publications/esbls-a-threat-to-human-and-animal- health (accessed 23 November 2013)
    • (2012) ESBLs: A Threat to Human and Animal Health
  • 3
    • 84892458585 scopus 로고    scopus 로고
    • Department of Health, (accessed 13 November 2013)
    • Department of Health (2013) Chief Medical Officer annual report: volume 2. www.gov.uk/government/ publications/chief-medical-officer-annual-report- volume-2 (accessed 13 November 2013)
    • (2013) Chief Medical Officer Annual Report , vol.2
  • 4
    • 38849113780 scopus 로고    scopus 로고
    • Market failure and the poverty of new drugs in maternal health
    • doi:10.1371/journal. pmed.0050022)
    • Fisk NM, Atun R (2008) Market Failure and the Poverty of New Drugs in Maternal Health. PLoS Medicine 5(1): e22 (doi:10.1371/journal. pmed.0050022)
    • (2008) PLoS Medicine , vol.5 , Issue.1
    • Fisk, N.M.1    Atun, R.2
  • 5
    • 84878488692 scopus 로고    scopus 로고
    • Public-private partnerships as driving forces in the quest for innovative medicines
    • doi: 10.1186/2001-1326-2-2
    • Goldman M, Compton C, Mittleman BB (2013) Public-private partnerships as driving forces in the quest for innovative medicines. Clin Transl Med 2(1): 2 (doi: 10.1186/2001-1326-2-2)
    • (2013) Clin Transl Med , vol.2 , Issue.1 , pp. 2
    • Goldman, M.1    Compton, C.2    Mittleman, B.B.3
  • 6
    • 84892464729 scopus 로고    scopus 로고
    • Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010
    • (Epub ahead of print) (doi: 10.1093/jac/ dkt349)
    • Head MG, Fitchett JR, Cooke MK et al (2013a) Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother Sep 13 (Epub ahead of print) (doi: 10.1093/jac/ dkt349)
    • (2013) J Antimicrob Chemother Sep , vol.13
    • Head, M.G.1    Fitchett, J.R.2    Cooke, M.K.3
  • 7
    • 84871052731 scopus 로고    scopus 로고
    • UK investments in global infectious disease research 1997-2010: A case study
    • doi: 10.1016/S1473-3099(12)70261-X)
    • Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R (2013b) UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis 13(1): 55-64 (doi: 10.1016/S1473-3099(12)70261-X)
    • (2013) Lancet Infect Dis , vol.13 , Issue.1 , pp. 55-64
    • Head, M.G.1    Fitchett, J.R.2    Cooke, M.K.3    Wurie, F.B.4    Hayward, A.C.5    Atun, R.6
  • 9
    • 84901987571 scopus 로고    scopus 로고
    • National Institute for Health Research, (accessed 14 October 2013)
    • National Institute for Health Research (2013) Antimicrobial Resistance Themed Call. www.themedcalls.nihr.ac.uk/amr (accessed 14 October 2013)
    • (2013) Antimicrobial Resistance Themed Call


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.